Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656052


The Europe Biotechnology Sectors : A Company and Industry Analysis (October 2004)


Description: This report looks at the biotechnology sectors in the European markets of France, Germany, The Netherlands, Sweden, Switzerland and the United Kingdom
Current Environment - Key Points
- There is an increasing gap between large and small biotech companies, primarily due to insufficient backing from venture capitalists to struggling, privately-financed firms
- Nevertheless, industry experts believe that the European Union's (EU) new member states could strengthen Europe's position in the biotech sector and the overall life sciences industry
- Many large pharmaceutical companies are collaborating with biotechs to exploit their drug- development capabilities
In return, pharmaceutical companies are offering biotechs funding, manufacturing and marketing services, and securing regulatory approval for products in development
- After a four-year financial drought, the European biotech industry is experiencing an investment upturn, which began in 2003
Since March, four biotech companies have posted initial public offerings (IPOs) - raising a combined US$345.3 million

Industry Profile - Key Points
- Although Europe has a strong, world-class biotech science base, the sector still lags in the number of commercial, scientific advances
- A fragmented market, coupled with pressure to lower manufacturing and R&D costs, and a climate that does not encourage or reward innovation, is also hindering the sector
- A lack of funding and investor confidence has forced companies to cut costs and research
Revenues for the European biotech industry fell 12% to about -11.3 billion (US$13.62 billion) in 2003
- Germany, the UK, France, Switzerland, the Netherlands and Scandinavian nations, especially Sweden, continue to be Europe's s biotech leaders
- The number of biotech companies in the major European countries has fallen from 1,340 in 2002 to 1,305 in 2003
- During the second quarter of 2004, investment in biotech and healthcare reached -482 million (US$580.91 million) in 56 deals, which was the second highest funding level ever seen since the same quarter in 2001
- On June 16, the European Commission (EC) outlined the main priorities for the upcoming 7th Research Framework Program (FP7), reaffirming the commitment to collaborative research in knowledge areas such as biotech
- On March 3, the EU adopted new health and safety standards for the donation, storage and use of human cells and tissues across the region
The EU now has comprehensive and binding requirements on the safety and quality of cells and tissues from donor to patient
Market Trends and Outlook - Key Points
- India is becoming a biotech hub for Europe's industry players
More and more European (and US) biotechs are moving their clinical trials and R&D activities to India
Also, leading Indian biotechnology companies are collaborating with partners across Europe
- Industrial biotech (also known as white biotech) looks set to spearhead the next revolution in manufacturing industries across the globe
It has been called the -third wave- of biotech after medicine and agriculture
- Europe is facing serious brain drain
Each year, more than 70% of Europeans who study in the US opt to stay
Consequently, about 40% of scientists working in the US are Europeans and some life sciences companies are moving their research operations overseas
- While Europe lags behind in agricultural biotech, it leads in areas such as genomics and stem cell research, thanks to a boost in support from regional and national policies
- While the biotech boom of 2000 was fueled by interest in genomics and platform technologies, experts say in the future biotech companies will focus more on innovative products


Contents: Current Environment
- Sector Overview
- Sector Development
- Alliances and Collaborations
- Initial Public Offerings
Industry Profile
- Industry Size and Value
- Industry Focus Areas
- Sector Investment
- Policy and Regulatory
Environment
Market Trends & Outlook
- Increasing European Biotech
Activities in India
- White Biotech: The Next Wave
- Europe's Brain Drain
Accelerates
- Market Outlook
Country Profiles
- France
- Germany
- Netherlands
- Sweden
- Switzerland
- United Kingdom
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Sales Contacts




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656052

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 21:44:27
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Europe Biotechnology Sectors : A Company and Industry Analysis (October 2004)
Web Address:
http://www.researchandmarkets.com/reports/656052
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €100.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 21:44:27

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)